Method for determining vitamin b12 uptake
US-2017254819-A1 · Sep 7, 2017 · US
US9655934B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9655934-B2 |
| Application number | US-201214128244-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 14, 2012 |
| Priority date | Jun 29, 2011 |
| Publication date | May 23, 2017 |
| Grant date | May 23, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for producing a dermatologically active yeast extract, comprising the following steps: providing a preculture of the yeast cells, culturing the cells for at least fifteen minutes at a pH of 1.8-4, harvesting the cells and lysing the cells, and a yeast extract produced thereby and products comprising said yeast extract.
Opening claim text (preview).
The invention claimed is: 1. A method of producing a dermatologically active yeast extract, said method comprising: providing a preculture of yeast cells selected from the group consisting of Yarrowia, Saccharomyces , and Pichia yeast cells; subjecting the preculture of yeast cells to an initial culturing step, wherein said initial culturing step is performed for at least 1 hour at a temperature of 34-39° C. and at a pH>5; culturing the yeast cells for at least fifteen minutes and at a pH of 1.8-4; harvesting the yeast cells; and lysing the yeast cells, wherein said lysis provides said yeast extract. 2. The method according to claim 1 , wherein said lysing is carried out using a water-based lysis agent. 3. The method according to claim 1 , wherein said culturing step is carried out at a temperature of 34-39° C. 4. The method according to claim 1 , wherein said initial culturing step lasts 3-5 hours. 5. The method according to claim 1 , wherein said culturing step lasts 45-75 minutes. 6. The method according to claim 1 , wherein said initial culturing step and said culturing step are carried out at a temperature of 36-38° C. 7. The method according to claim 1 , wherein said culturing step is carried out at a pH of 1.9-2.2. 8. The method according to claim 1 , wherein said initial culturing step is carried out for 3-5 hours at a temperature of 36-38° C., said culturing step is carried out at a pH of 1.9-2.2, at a temperature of 36-38° C. and for 45-75 minutes and the yeast cells are yeast cells of the genus Yarrowia .
Drugs for disorders of the cardiovascular system · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Nutrients, e.g. vitamins, minerals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.